Maze Therapeutics Inc (MAZE)

R&D Expense Growth

3.67%

Quarterly · Period ending:

MAZE logo

MAZE R&D Expense Growth

Latest reported3.67%
MAZE Quarterly R&D Growth (QoQ) (0.00% → 3.67%)
High-resolution chart · PNG

MAZE r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Maze Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
3.6672%
22.2488%
9.4482%
-10.3814%
1.9144%
24.1448%
11.8799%
1.5911%
-10.655%
36.3478%
-17.5403%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.